Liver Failure in an Antimitochondrial Antibody-Positive Patient with Sarcoidosis: Primary Biliary Cirrhosis or Hepatic Sarcoidosis?

Carmen M. Stanca; M. Isabel Fiel; Jorge Allina; Cynthia F. Caracta; Joseph A. Odin

doi:10.1055/s-2005-916327

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2005; 25(3): 364-370
DOI: 10.1055/s-2005-916327

DIAGNOSTIC PROBLEMS IN HEPATOLOGY

Liver Failure in an Antimitochondrial Antibody-Positive Patient with Sarcoidosis: Primary Biliary Cirrhosis or Hepatic Sarcoidosis?

Carmen M. Stanca¹ , M. Isabel Fiel² , Jorge Allina¹ , Cynthia F. Caracta¹ , Joseph A. Odin¹

¹Department of Medicine, Mount Sinai School of Medicine, New York, New York
²Department of Pathology, Mount Sinai School of Medicine, New York, New York

Abstract

Full Text

References

REFERENCES

1 Eklund A, Stjernberg N, Uddenfeldt P, Danielsson A. Kveim test and mitochondrial antibodies in the differential diagnosis between primary biliary cirrhosis and sarcoidosis. Sarcoidosis. 1985; 2 38-41
2 Chung K I, Friedman L S. Liver abscess and bacterial, parasitic fungal, and granulomatous liver disease. In: Feldman M, Friedman LS, Sleisenger M Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management Philadelphia, PA; W.B. Saunders 2002: 1343-1363
3 Valla D C, Benhamou J P. Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis. 2000; 4 269-285
4 Paramothayan S, Jones P W. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA. 2002; 287 1301-1307
5 Gibson G J, Prescott R J, Muers M F et al.. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax. 1996; 51 238-247
6 Wolfhagen F H, van Buuren H R, Schalm S W. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. Neth J Med. 1994; 44 84-90
7 Wolfhagen F H, van Hoogstraten H J, van Buuren H R et al.. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. J Hepatol. 1998; 29 736-742
8 Kim W R, Lindor K D, Locke III G R et al.. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000; 119 1631-1636
9 Prezant D J, Dhala A, Goldstein A et al.. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest. 1999; 116 1183-1193
10 Pereira-Lima J, Schaffner F. Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Report of two cases. Am J Med. 1987; 83 144-148
11 Leff J A, Ready J B, Repetto C, Goff J S, Schwarz M I. Coexistence of primary biliary cirrhosis and sarcoidosis. West J Med. 1990; 153 439-441
12 Stanley N N, Fox R A, Whimster W F, Sherlock S, James D G. Primary biliary cirrhosis or sarcoidosis-or both. N Engl J Med. 1972; 287 1282-1284
13 Maddrey W C. Sarcoidosis and primary biliary cirrhosis. Associated disorders?. N Engl J Med. 1983; 308 588-590
14 Nakanuma Y, Ohta G, Yamazaki Y, Doishita K. Intrahepatic bile duct destruction in a patient with sarcoidosis and chronic intrahepatic cholestasis. Acta Pathol Jpn. 1979; 29 211-219
15 Munoz L E, Thomas H C, Scheuer P J, Doniach D, Sherlock S. Is mitochondrial antibody diagnostic of primary biliary cirrhosis?. Gut. 1981; 22 136-140
16 Lacerda M A, Ludwig J, Dickson E R, Jorgensen R A, Lindor K D. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol. 1995; 90 247-249
17 Rudzki C, Ishak K G, Zimmerman H J. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med. 1975; 59 373-387
18 Bass N M, Burroughs A K, Scheuer P J, James D G, Sherlock S. Chronic intrahepatic cholestasis due to sarcoidosis. Gut. 1982; 23 417-421
19 Tanaka A, Miyakawa H, Luketic V A, Kaplan M, Storch W B, Gershwin M E. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis. Cell Mol Biol. 2002; 48 295-299
20 Zuber M A, Recktenwald C. Clinical correlation of antimitochondrial antibodies. Eur J Med Res. 2003; 8 61-70
21 Vrethem M, Skogh T, Berlin G, Ernerudh J. Autoantibodies versus clinical symptoms in blood donors. J Rheumatol. 1992; 19 1919-1921
22 Yanagawa T, Miyakawa H, Shibata M et al.. Immunoreactivity to pyruvate dehydrogenase complex-E2 in well-defined patients with autoimmune hepatitis: Western blot analysis. Hepatol Res. 2003; 26 81-86
23 Miyakawa H, Kawaguchi N, Abe K et al.. Serial changes of serum anti-M2 proteins in patients with primary biliary cirrhosis: a follow-up study by immunoblotting. Hepatol Res. 1999; 13 143-152
24 Ishii H, Saifuku K, Namihisa T. Reactivities and clinical relevance of antimitochondrial antibodies to four mitochondrial inner membrane proteins in sera of patients with primary biliary cirrhosis. Hepatology. 2000; 7 134-136
25 Kitami N, Ishii H, Shimizu H et al.. Immunoreactivity to M2 proteins in antimitochondrial antibody-negative patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2000; 9 7-12
26 Van de Water J, Cooper A, Surh C D et al.. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med. 1989; 320 1377-1380
27 Spiteri M A, Clarke S W. The nature of latent pulmonary involvement in primary biliary cirrhosis. Sarcoidosis. 1989; 6 107-110
28 Wallace Jr J G, Tong M J, Ueki B H, Quismorio F P. Pulmonary involvement in primary biliary cirrhosis. J Clin Gastroenterol. 1987; 9 431-435
29 Weissman E, Becker N H. Interstitial lung disease in primary biliary cirrhosis. Am J Med Sci. 1983; 285 21-27
30 Neschwander-Tetri B. Bacterial, parasitic, fungal, and granulomatous liver diseases. In: Goldman L, Ausiello D Cecil Textbook of Medicine. Vol. 1, 22nd ed. Philadelphia, PA; W.B. Saunders 2004: 924-931
31 McCluggage W G, Sloan J M. Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathology. 1994; 25 219-228
32 Gaya D R, Thorburn D, Oien K A, Morris A J, Stanley A J. Hepatic granulomas: a 10 year single centre experience. J Clin Pathol. 2003; 56 850-853
33 Reynolds H Y. Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung. 2002; 180 281-299
34 Baughman R P, Teirstein A S, Judson M A et al.. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164 1885-1889
35 Mayock R L, Bertrand P, Morrison C E, Scott J H. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med. 1963; 35 67-89
36 Siltzbach L E. Sarcoidosis: clinical features and management. Med Clin North Am. 1967; 51 483-502
37 Johns C J, Michele T M. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore). 1999; 78 65-111
38 Keeffe E B. Sarcoidosis and primary biliary cirrhosis. Literature review and illustrative case. Am J Med. 1987; 83 977-980
39 Devaney K, Goodman Z D, Epstein M S, Zimmerman H J, Ishak K G. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol. 1993; 17 1272-1280

Carmen M StancaM.D.

Department of Medicine, Mount Sinai School of Medicine

One Gustave L. Levy Place, New York, NY 10029

Email: Carmen.Stanca@mssm.edu